Information  X 
Enter a valid email address

Futura Medical narrows annual losses on lower R&D spend

By BFN News | 10:10 AM | Wednesday 14 April, 2021

Pharmaceutical company Futura Medical reported narrower losses as research and development spend fell sharply. For the year ended 31 December 2020, pre-tax losses narrowed to £2.9 million from £11.1 million. Research and development costs fell to £1.9 million from £10.0 million. 'The company is well positioned to deliver further positive news through 2021 especially around commercialisation of MED3000 and our objective to deliver a long term and sustainable revenue for shareholders,' the company said. At 10:10am: (LON:FUM) Futura Medical PLC share price was 0p at 14.75p Story provided by

a d v e r t i s e m e n t